Glenmark Investigational Site 1

Hackensack, New Jersey 07601

We've found

1 trials

at this facility

Study of GBR 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Hackensack, NJ

Use our guide to learn which trials are right for you!